BN Business News
Add your company to Business Communicator →

Business · 03/11/20261 min read

Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition

Summary

The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across China. HANGZHOU, China, Nov.

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →